Fractyl Health, Inc.
GUTS
$1.50
-$0.13-7.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.19% | -47.16% | -- | -- | -60.74% |
| Total Depreciation and Amortization | 486.84% | 148.81% | -- | -- | -52.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.67% | -8.38% | -- | -- | 448.16% |
| Change in Net Operating Assets | 318.22% | 768.85% | -- | -- | 23.16% |
| Cash from Operations | -60.71% | -63.72% | -- | -- | -10.98% |
| Capital Expenditure | -71.32% | -43.92% | -- | -- | -580.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -71.32% | -43.92% | -- | -- | -580.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,433.33% | 24.68% | -- | -- | -50.00% |
| Issuance of Common Stock | 917.65% | 4,300.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | 112.05% | -99.42% | -- | -- | -27,700.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.33% | -207.67% | -- | -- | -17.96% |